Physical Problems in Fragile X Syndrome

Consensus of the Fragile X Clinical & Research Consortium

Updated: October 2012

Reading time: 08 mins

Open as PDF:

English

Summary

Multiple associated physical problems can occur with FXS, mostly related to loose connective tissue. These include hypotonia, hyperflexibility, flat feet, recurrent ear infections, and mitral valve prolapse. Seizures, precocious puberty, and ophthalmic issues can also be present.

Table of Contents

    Introduction

    Fragile X syndrome (FXS) is a medical disorder caused by a mutation in the FMR1 gene. Its systemic effects are most noticeable in the cognitive behavioral domain, but multiple associated physical problems mostly related to loose connective tissue can occur. These include hypotonia (low muscle tone), hyperflexibility, flat feet, recurrent ear infections, and mitral valve prolapse (a common heart condition where the mitral valve does not close properly). Seizures, precocious (early) puberty, and ophthalmic issues (eye disorders) can also be present.

    At this time there is no definitive specific treatment for these problems. Management is therefore largely empiric and, depending upon the individual, may include drug or other modalities but typically involves the combined efforts of a multidisciplinary team including ideally, psychology, developmental and behavioral pediatrics, neurology, speech and occupational therapy, neurology, psychiatry and genetics.

    Diagnosis and Recognition

    Diagnosis of FXS is the key to management. The disorder should be tested for in every child (male or female) with unexplained intellectual disability as well as in the offspring of premutation and full mutation carrier mothers, and considered for girls with significant processing and behavioral issues.

    Following diagnosis, potential problems should be actively investigated and managed accordingly. This evaluation can be carried out systemically as, for example, via the guideline below taken from the Fragile X health watch table, which includes specific recommendations for the following:

    • A detailed history — actively enquiring for motor and language delays, autistic symptoms, behavioral profile, characterization of sleep, feeding, seizures, ear infections, dislocations, and in girls, relevant menstrual history
    • A detailed physical exam — specifically check for hypotonia, heart murmur, blood pressure, flexibility, pes planus, joint dislocations, hernias, scoliosis, weight, strabismus/refraction, dentition and, if applicable, signs of puberty
    • Evaluation — specifically for speech and hearing; fine motor and sensory integration (occupational therapy evaluation); psychometrics (IQ, behavioral profile including evaluation for anxiety, ADHD and autism when clinically indicated)

    Current Treatment Guidelines

    Cognitive Deficits

    Developmental and behavioral pediatricians and psychologists should provide a working plan, ideally integrated with the early intervention service or the school’s IEP (individualized education program). Speech is typically delayed and speech and language pathology should be involved if there is any deficit, as assisting communication is typically a complex issue. Cognitive services may need to be coordinated with behavioral and sensory recommendations.

    Behavioral Issues

    Following assessment by the psychologist and occupational therapist, a plan should be devised, again ideally integrated with school services. Additional inhome support may be needed. Not infrequently, pharmacologic intervention is necessary. It should always be provided together with behavior therapy. In general medications for similar mental health concerns used in children without FXS (stimulants, alpha agonists, SSRI’s, atypical antipsychotics) are also useful for children with FXS. Medications generally to be avoided include gabapentin (which appears to be unhelpful) and topamax (because of its cognitive dulling effect). A number of other medications which function as mGluR antagonists and may be specifically helpful for individuals with FXS are being currently being evaluated.

    Related Recommendations
    Behavioral Challenges in Fragile X Syndrome

    The most common behavioral challenges seen in FXS include those associated with generalized anxiety, social interaction difficulties, ADHD, self-injury, and aggression.

    Medications for Individuals with Fragile X Syndrome

    Medications are, at times, helpful to facilitate the individual’s ability to attain optimal life skills and allow for better integration into educational, adult, and social environments.

    Ear Infections

    Early referral to an otolaryngologist is recommended, as many children with FXS will need myringotomy tubes. The majority suffer from recurrent ear infections, for which an aggressive approach is recommended.

    Hypotonia

    Evaluation and management by physiotherapy is recommended. Ideally, early intervention services will commence in infancy.

    Related Recommendations
    Early Childhood Developmental and Educational Guidelines for Children with Fragile X Syndrome

    For all children within the early childhood age range of birth to 5 years and especially for young children with identified disabilities associated with a diagnosis like Fragile X syndrome (FXS), inclusive, nurturing, and developmentally appropriate environments and caregiving are essential to growth and development.

    Seizures

    Typically these occur post infancy/early childhood and are often complex partial, though all types of seizures can occur. Usually they are readily managed on standard monotherapy, though care should be taken to avoid drugs which cause connective tissue hyperplasia, e.g., phenytoin, as this can be disfiguring. EEG abnormalities are more common than frank seizures, and any suspicion of seizure should be evaluated by a neurologist, ideally one with experience in FXS. Medications proven to be helpful include carbamazepine and valproic acid. Good results are also occurring with newer generation AEDs.

    Related Recommendations
    Seizures in Fragile X Syndrome

    Based on study data, 12% of people with Fragile X syndrome have seizures, and treatment and management are similar to seizure treatment in other conditions associated with seizures. They are easily controlled in Fragile X syndrome and most patients grow out of their seizures before their 20s.

    Autism

    Applied behavior analysis therapy is recommended, likely provided in conjunction with sensory integration techniques. It is also important to note that gaze aversion is a sensory overstimulating effect in individuals with FXS, rather than a reflection of socially cued indifference.

    Related Recommendations
    Understanding Autism Spectrum Disorder in Fragile X Syndrome

    Clarification on how the ASD diagnosis and FXS do and do not overlap. Understanding this distinction can be particularly helpful for genetic counseling and deciding on the most appropriate interventions.

    Connective Tissue Problems

    Connective tissue problems include pes planus (flat feet or fallen arches), scoliosis (curved spine), pectus excavatum (breastbone and ribs curve inward, also known as funnel chest), and hyperflexibility (muscles and tendons to stretch beyond their normal range). Orthotic support (and occasionally braces) are often required, as is referral to
    orthopedics.

    Heart Murmur

    Mitral valve prolapse occurs at a greater frequency in FXS from late adolescence onwards. However, if there are concerns, an echocardiogram or cardiology evaluation should be undertaken.

    Frequently Asked Questions

    What should I tell my patients?

    Fragile X syndrome is a genetic disorder with cognitive/behavioral and systemic effects that are present in varying degrees from one individual to another. There is no cure but there are treatments that can help the symptoms and signs. Life expectancy is in the normal range though affected individuals will typically need life-long support and care. IQ for males is typically in the 50-70 range, but with areas of relative strength.

    Females are often in the borderline-to-normal IQ range, though some are as affected as males. Novel research treatments are currently under investigation, which may improve the outlook for the future. As the disorder is genetic, it is important to ensure that no other family members are affected or at risk for symptoms related to being a carrier.


    What are the expected benefits or side effects of treatment?

    An active approach to treatment can ensure that affected individuals will optimize their potential. In addition, affected individuals are often responsive to standard treatments, though as with all people, side effects may have an impact. Given the cognitive and behavioral aspects of the condition, side effects may present primarily as behavioral or atypical changes.


    What to do in acute situations?

    In general, FXS does not cause acute emergency problems. In rare cases, seizures will require emergency treatment and should be managed in the acute setting as they are with individuals without FXS. More commonly, behaviorally related problems such as aggressive outbursts or impulsive running away will precipitate a crisis situation. In such instances, the child should be taken to a familiar location with a “safe” room. This will usually allow the trauma to recede and the precipitant can be managed in a calmer manner.

    Fragile X Syndrome Health Watch Table

    Forster-Gibson, Cynthia, MD, PhD; Berg, Joseph M, MB, BCH, MSC, FRCPSYCH, FCCMG. Also available as a PDF.

    ConsiderationsRecommendations
    1. HEENT (HEAD, EYES, EARS, NOSE, THROAT)
    Children: Strabismus, refractive errors, recurrent otitis media and sinusitis are common✔️ Undertake newborn screening and auditory brainstem response (ABR). Arrange comprehensive ophthalmologic examination by 4 years of age
    ✔️ Visualize tympanic membranes at each visit
    Adults: Strabismus, refractive errors are common✔️ Undertake hearing and vision screening at each visit, with particular attention to hearing loss and myopia
    2. DENTAL
    Children & Adults: High arched palate and dental malocclusion are common✔️ Initiate annual dental exam
    3. CARDIOVASCULAR
    Children: Mitral valve prolapse (MVP) is uncommon in children (≤10%), but may develop during adolescence✔️ Auscultate for murmur or click at each visit. If present, do ECG and echocardiogram; refer to cardiologist if indicated
    Adults: MVP is common (≤80%); Aortic root dilation usually not progressive. Hypertension may be related to anxiety.✔️ Undertake clinical exam, ECG, and echocardiogram with referral to cardiologist as appropriate
    ✔️ Measure BP at each visit but at least annually
    4. RESPIRATORY
    Children: Obstructive sleep apnea (OSA) may be due to enlarged adenoids, hypotonia, or connective tissue dysplasia✔️ Ascertain sleep history for signs of OSA
    ✔️ Do sleep study as appropriate
    Adults: Obstructive sleep apnea (OSA) may occur✔️ Recommendations as for children
    5. GASTROINTESTINAL
    Children: In infants, feeding problems are common with recurrent emesis associated with Gastroesophageal Reflux in >30% of infants✔️ Refer for assessment of gastroesophageal reflux disease (GERD). Thickened feedings and upright positioning may be adequate treatment
    6. GENITOURINARY
    Children: Inguinal hernia is relatively common in males. Macroorchidism generally develops in late childhood/early adolescence. Persistent ureteral reflux may occur.✔️ Assess for inguinal hernia beginning at age 1 year
    ✔️ Macroorchidism can be measured with an orchidometer and reassure parents that it does not require treatment
    ✔️ Evaluate recurrent urinary tract infections (UTI) with cystourethrogram and renal ultrasound and refer to nephrology or urology as needed
    ✔️ Consider renal etiology for persistent hypertension
    Adults: Inguinal hernia is relatively common in males. Macroorchidism persists.✔️ Assess periodically for inguinal hernia
    ✔️ Macroorchidism does not require treatment
    7. SEXUAL FUNCTION
    Adults: Males and females are fertile✔️ Consider discussion of recurrence risk and reproductive options as a basis for referral to a genetics clinic. Make such a referral even if FXS is only suspected so that molecular testing can be undertaken in the person concerned and relevant family members.
    8. MUSCULOSKELETAL
    Children: Hyperextensible joints and pes planus are common. Scoliosis, clubfoot, joint dislocation (particularly congenital hip) may also occur.✔️ Undertake physical exam at birth and then every 4 months
    ✔️ Elicit history of dislocations
    ✔️ Make orthopedics referral as dictated by clinical findings
    ✔️ Consider physiotherapy referral, orthotics
    Adults: Hyperextensible
    joints and pes planus are
    common. Scoliosis, joint
    dislocation may also occur.
    ✔️ Assess at regular physical exam
    ✔️ Make orthopedics referral as dictated by clinical findings
    ✔️ Consider physiotherapy referral, orthotics
    9. NEUROLOGY
    Children: ± 20% have epilepsy (may include generalized tonic-clonic seizures, staring spells, partial motor seizures and temporal lobe seizures)✔️ Ascertain history of seizures which usually present in early childhood
    ✔️ Arrange EEG if seizures are suspected from medical
    history
    ✔️ Obtain neurology consult as dictated by clinical findings
    Adults: Seizures
    occasionally persist into
    adulthood
    ✔️ Assess for atypical seizures if suspicious symptoms exist or intellectual function decreases
    ✔️ Arrange EEG if seizures are suspected from medical
    history
    ✔️ Obtain neurology consult as dictated by clinical findings
    10. ENDOCRINE
    Children: Precocious puberty may occur✔️ Include attention in clinical examination to signs of precocious puberty in females. Refer to endocrinologist for consideration of use of gonadotropin agonist to block precocious puberty.
    ✔️ Note presence of macroorchidism and reassure parents
    Adults✔️ Ascertain history with attention to menstruation, anxiety, depression, and mood lability. If PMS symptoms are severe enough, consider a serotonin agent to stabilize mood.
    © Developmental Disabilities Primary Care Initiative July 2009

    Notes and References

    Author’s Note

    This guideline was authored by Jonathan Picker, MD, PhD, and Carol Delahunty, MD, and was and reviewed and edited by consortium members both within and external to its Clinical Practices Committee. It has been approved by and represents the current consensus of the members of the Fragile X Clinical & Research Consortium.

    Funding

    This project was made possible by Cooperative Agreement U01DD000231 from the Centers for Disease Control and Prevention to the Association of University Centers on Disabilities (AUCD) and RTOI 2008-999-03 from AUCD to W.T. Brown in support of the National Fragile X Clinical and Research Consortium. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

    References

    1. Alanay, Y., Unal, F., Turanli, G., Alikaşifoğlu, M., Alehan, D., Akyol, U., Belgin, E., Sener, C., Aktaş, D., Boduroğlu, K., Utine, E., Volkan-Salanci, B., Ozusta, S., Genç, A., Başar, F., Sevinç, S., & Tunçbilek, E. (2007). A multidisciplinary approach to the management of individuals with fragile X syndrome. Journal of intellectual disability research : JIDR, 51(Pt 2), 151–161. https://doi.org/10.1111/j.1365-2788.2006.00942.x

    2. Hagerman, R. J., Berry-Kravis, E., Kaufmann, W. E., Ono, M. Y., Tartaglia, N., Lachiewicz, A., Kronk, R., Delahunty, C., Hessl, D., Visootsak, J., Picker, J., Gane, L., & Tranfaglia, M. (2009). Advances in the treatment of fragile X syndrome. Pediatrics, 123(1), 378–390.